Drug Profile
BL 1060
Alternative Names: BL-1060Latest Information Update: 09 May 2007
Price :
$50
*
At a glance
- Originator Galmed International
- Class Small molecules
- Mechanism of Action Cholesterol inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Liver disorders; Non-alcoholic steatohepatitis
Most Recent Events
- 13 Apr 2005 Preclinical trials in Liver disorders in Israel (PO)
- 13 Apr 2005 Preclinical trials in Non-alcoholic steatohepatitis in Israel (PO)